Cowen raised its price target on Insmed (NASDAQ: INSM) to $56.00 (from $54.00) while maintaining a Outperform rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE